On August 1, 2013, PharmaVOICE included Rachel King, CEO of GlycoMimetics, among the 2013 PharmaVOICE 100 list.
Established nine years ago by PharmaVOICE magazine, the PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life-sciences industry. These individuals illustrate what it means to think bigger, do more, and lead with passion and integrity. The distinguished honorees are nominated by thousands of PharmaVOICE readers throughout the year and are selected based on well-crafted and comprehensive essays describing how they have inspired or motivated their colleagues, peers, and even competitors; have affected positive changes in their own organizations; as well as other factors, such as community and philanthropic activities.
The PharmaVOICE 100 honorees represent a broad cross section of industry sectors, including pharmaceutical, biopharmaceutical, biotechnology, contract research, clinical trial, research and development, patient education, patient recruitment, advertising, marketing, technology, and many others.
View the 2013 list of the PharmaVOICE 100, including Rachel King, at: http://www.pharmavoice.com/